TOTUM•63

N/A

Report date: 2022/11/05 14:35:17

Base Information

Drug NameTOTUM•63
Drug Alias NameTOTUM-63
ClassificationNatural product/Extract > Plants extract
Mechanisms of ActionInsulin receptor agonistsDipeptidyl peptidase IV inhibitorsProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsInsulin receptorDipeptidyl peptidase IVProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesValbiotis
China Registration ClassN/A

Develop Information

Active CompaniesValbiotis
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A